Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0007570 (
celiac disease
)
13,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Celiac disease
is probably the best-understood immune-related disorder. The disease presents in the small intestine and results from the interplay between multiple genes and gluten, the triggering environmental factor. Although HLA class II genes explain 40% of the heritable risk, non-HLA genes accounting for most of the familial clustering have not yet been identified. Here we report significant and replicable association (P = 2.1 x 10(-6)) to a common variant located in intron 28 of the gene myosin IXB (
MYO9B
), which encodes an unconventional myosin molecule that has a role in actin remodeling of epithelial enterocytes. Individuals homozygous with respect to the at-risk allele have a 2.3-times higher risk of
celiac disease
(P = 1.55 x 10(-5)). This result is suggestive of a primary impairment of the intestinal barrier in the etiology of
celiac disease
, which may explain why immunogenic gluten peptides are able to pass through the epithelial barrier.
...
PMID:Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. 1628 76
Association between myosin IXB (
MYO9B
) gene variants and
celiac disease
(CD) has been reported in a study of a Dutch cohort. Six single nucleotide polymorphisms (SNPs) within the 3' part of the
MYO9B
gene showed significant genetic association and formed an associated haplotype. The current study aimed to replicate these findings in a Swedish/Norwegian cohort. Genotyping of the three SNPs which tagged the associated haplotype was performed in a CD family dataset (n = 326) and in an additional set of healthy controls (n = 562). Although our material provided reasonable power to detect the previously observed association, we were unable to replicate association with these SNPs. Lack of reproducibility could be explained by no or negligible contribution of
MYO9B
to the genetic predisposition to CD in the Swedish/Norwegian population. Alternatively, it might be due to variable linkage disequilibria in distinct populations in the tested SNPs and a causative mutation yet to be identified or to false positive findings (type I error) in the Dutch study.
...
PMID:Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. 1672 Feb 15
Association between Myosin IXB (
MYO9B
) gene polymorphisms and
celiac disease
(CD) was recently detected by a case-control association study in the Dutch, but not confirmed in the British and Swedish/Norwegian populations. We tested the association between CD and the three most associated single nucleotide polymorphisms (SNPs) in the Dutch study by the transmission disequilibrium test in the Italian population. A total of 252 pediatric patients and 504 parents were genotyped. No transmission distortion was detected either for the single SNPs or for their haplotypic combinations. Control allele frequencies, calculated from untransmitted alleles, were significantly different from those of the Dutch control population. Conversely, allele frequencies were very similar in Italian, British, Swedish/Norwegian and Dutch patients. In conclusion,
MYO9B
is not involved in CD susceptibility in the Italian population. The difference with the Dutch result might be explained by an imperfect selection of the Dutch controls.
...
PMID:A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. 1694 98
Association between single nucleotide polymorphisms (SNPs) within the
MYO9B
gene and
celiac disease
was recently reported. The role of
MYO9B
in
celiac disease
was suggested to relate to an epithelial barrier defect. The region to which
MYO9B
localize is also linked with inflammatory bowel disease (IBD). For these reasons, we hypothesize that
MYO9B
could also be a susceptibility gene in IBD. To address this, we performed an association study of a Norwegian IBD cohort (149 patients with Crohn's disease, 308 patients with ulcerative colitis and 562 healthy controls) using SNPs, which tagged the
celiac disease
associated
MYO9B
haplotype. No association between these SNPs and IBD was observed. Our results failed to support the notion that
MYO9B
is a susceptibility gene in IBD.
...
PMID:Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. 1694 47
Inconsistent results concerning the association of polymorphisms in the
MYO9B
gene with
celiac disease
(CD) have been recently published. This gene encodes a myosin with a guanosine-triphosphatase (GTPase)-activating protein domain for the Rho-family of small G proteins, which are involved in cytoskeleton remodeling and therefore potentially involved in intestinal permeability. Functional and positional reasons led us to investigate the role of
MYO9B
polymorphisms in the Spanish CD population. A case-control study, including 415 CD patients and 433 ethnically matched healthy controls, and a familial study, including parents of 145 of those CD patients, was performed. Six
MYO9B
variants previously associated with CD were analyzed: rs2305767, rs2279003, rs962917, rs1457092, rs2305765 and rs2305764. No
MYO9B
variants or
MYO9B
haplotypes were found associated with CD, either before or after stratification of the patients for the human leucocyte antigen (HLA)-DQ2-positive risk factor. The family study revealed no distorted transmission of the aforementioned
MYO9B
polymorphisms or haplotypes. Our results support a negligible influence of this gene on CD predisposition.
...
PMID:No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. 1717 39
Celiac disease
(CD) is characterized by a chronic immune reaction in the small intestine to the gluten proteins that are present in a (Western) daily diet. Besides the well known involvement of the HLA class II histocompatibility antigen (HLA)-DQ2.5 and -DQ8 heterodimers (encoded by particular combinations of the HLA-DQA1 and -DQB1 gene) in CD and the minor contribution of the CTLA-4 gene, recently the myosin IXB (
MYO9B
) gene has also been found to be genetically associated. This review covers the general aspects of CD as well as current insight into important molecular aspects. We evaluate the role of susceptibility genes in CD by following gluten along its path from ingestion to uptake in the body, which leads us through the three aspects of CD's pathology. The first is the presence of gluten in the lumen of the intestine, where it is broken down by several enzymes. The second is the intestinal barrier through which gluten peptides pass. The third is the reaction of the immune system in response to gluten peptides, in which both the innate and the adaptive immune systems play a role. Our main conclusion, based on the current genetic and functional studies, is that we should look for causal genes in the barrier function as well as in the immune systems.
...
PMID:Understanding the molecular basis of celiac disease: what genetic studies reveal. 1743 72
The aim of the study was to test
MYO9B
gene polymorphisms for association with three autoimmune diseases, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and
celiac disease
(CD), in a Spanish population. We analyzed three SNPs (rs2305767, rs1457092, and rs2305764) in a case-control cohort composed of 349 SLE patients, 356 RA patients, 90 CD patients, and 345 healthy controls. All three SNPs showed a consistent increased frequency of the A allele in SLE, RA, and CD patients compared with healthy controls. An association was observed between CD and rs2305764 (p=0.01, OR=2.3), between SLE and rs1457092 (p=0.002, OR=1.4), and between RA and rs1457092 (p=0.02, OR=1.3). The three autoimmune diseases combined showed significant association with rs1457092 and rs2305764 and with the AAA haplotype (p haplotype=0.005, OR=1.3). Our data demonstrate consistent association with the A allele and AAA haplotype of three SNPs in the
MYO9B
gene, which were previously reported to be associated with CD in the Dutch population. This suggests that genetic variation in
MYO9B
is associated with CD, SLE, and RA and that
MYO9B
is a general risk factor for autoimmunity.
...
PMID:MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. 1758 84
There has long been discussion on the correlation between schizophrenia and autoimmune diseases (especially
celiac disease
), which makes the recently discovered
celiac disease
risk factor,
MYO9B
, an attractive functional and positional candidate gene for schizophrenia. To test this hypothesis we compared allele frequencies of three
MYO9B
tag SNPs in 315 schizophrenia cases and 1,624 healthy controls in a genetic association study. Highly significant differences in allele frequencies between schizophrenia cases and healthy controls were observed for SNP rs2305767 in intron 14 of
MYO9B
(P = 1.16 x 10(-4); OR 1.41, 95% CI 1.18-1.67). We demonstrate significant association of allelic variants in
MYO9B
with schizophrenia. To our knowledge, this is the first molecular genetic evidence for a correlation between autoimmune diseases and the risk of developing schizophrenia.
...
PMID:Is MYO9B the missing link between schizophrenia and celiac disease? 1794
MYO9B
(myosin IXB) polymorphisms were associated with
celiac disease
and ulcerative colitis susceptibility, presumably through alteration of the intestinal permeability. Recently this gene was also associated with several diseases with an autoimmune component, such as rheumatoid arthritis and systemic lupus erythematosus. We aimed to test, for the first time, the potential role of
MYO9B
polymorphisms in type 1 diabetes (T1D), an autoimmune condition preceded by changes in intestinal barrier integrity. Three previously associated
MYO9B
polymorphisms (rs962917, rs2279003, and rs2305764) were studied in 316 T1D patients and 706 ethnically matched controls. Minor alleles of those polymorphisms were more frequent in diabetic patients than in controls and the haplotype carrying major alleles in those positions, rs962917*G/rs2279003*C/rs2305764*G, significantly reduced the risk of T1D in the Spanish population (p = 0.004; OR [95% confidence interval] = 0.68 [0.52-0.90]). Our data suggest an involvement of this
MYO9B
chromosomal region in T1D predisposition, indicating extensive influence on autoimmune diseases.
...
PMID:Association of MYO9B haplotype with type 1 diabetes. 1836 36
Various genes may influence intestinal barrier function, including MAGI2,
MYO9B
, and PARD3, which are associated with
celiac disease
. Because direct measurement of intestinal permeability is difficult, antibodies against gliadin (AGA) and Baker's yeast (anti-Saccharomyces cerevisiae antibodies [ASCA]) can be used as an indirect test. The objective of this study was to investigate whether intestinal permeability, represented by AGA, was correlated with MAGI2,
MYO9B
, and PARD3. Analyses were performed in patients with Down syndrome, a population with suspected increased intestinal permeability. Correlations between AGA and ASCA were investigated. Patients with Down syndrome (n = 126) were genotyped for six single-nucleotide polymorphisms in MAGI2 (rs1496770, rs6962966, rs9640699),
MYO9B
(rs1457092, rs2305764), and PARD3 (rs10763976). An allele dosage association of these risk genes and AGA levels was performed. The correlation between AGA and ASCA was studied. A strong correlation was found between AGA and ASCA (p < 0.01). The patient group with one or more risk genotypes had lower mean AGA levels (trend test p = 0.007) and consisted of a larger number of patients with normal AGA levels (p = 9.3 x 10(-5)). Celiac-associated risk genotypes are associated with lower AGA values instead of elevated ones. Thus, other immunologic phenomena play a role in the increased prevalence of elevated AGA in patients with Down syndrome, possibly involving altered induction and/or maintenance of tolerance.
...
PMID:Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability. 2009 42
1
2
Next >>